Tedence

Company Overview

Snapshot

Founded in September 2022 by Morris Laster, Tedence operates with 1–10 employees. The company is currently in the Pre-Funding stage and is developing an AI-powered therapeutic platform. In September 2023, Tedence was featured for its innovative approach to managing juvenile diabetes.

Business overview

Tedence is an AI-powered healthcare platform specializing in personalized therapeutic solutions for chronic and autoimmune diseases. The company's core technology involves utilizing artificial intelligence to create bioelectric treatments delivered through wearable technology. Tedence aims to address conditions such as diabetes, operating within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Biomaterials & Tissue Engineering.

Strategic signal

In September 2023, Tedence gained recognition for its innovative development in addressing juvenile diabetes. This highlights the company's potential to leverage its AI-powered bioelectric treatments for specific chronic conditions, signaling a focused and impactful application of its technology within the health tech market.

Company Intelligence Q&A

When was Tedence founded and by whom?

Tedence was founded in September 2022 by Morris Laster, who serves as the Founder & CEO.

What is Tedence's primary focus in healthcare?

Tedence focuses on creating a personalized therapeutic platform using artificial intelligence for chronic and autoimmune diseases, employing bioelectric treatments via wearable technology.

What is the current employee size of Tedence?

Tedence currently operates with 1–10 employees.

In which sector does Tedence primarily operate?

Tedence's primary sector is Health Tech & Life Sciences, with a focus on Pharma & Medical Biotechnology and Biomaterials & Tissue Engineering.

What notable recognition did Tedence receive in 2023?

In September 2023, Tedence was recognized for its innovative development in addressing juvenile diabetes, as reported by Maariv.